BioCentury | Oct 24, 2011
Product Development

Alzheimer's rewind

...Nanotherapeutics Inc. PRX-3140 Serotonin (5-HT4) receptor agonist Ph II Suven Life Sciences Ltd. (NSE:SUVEN; BSE:530239) SUVN-502...
BioCentury | Jun 23, 2008
Clinical News

SUVN-502: Phase I start

...oral SUVN-502 in 67 healthy volunteers. Suven Life Sciences Ltd. (NSE:SUVEN; BSE:530239), Hyderabad, India Product: SUVN-502...
Items per page:
1 - 2 of 2